Centers for Disease Control and Prevention Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z site search
National Office of Public Health Genomics
Centers for Disease Control and Prevention
Office of Genomics and Disease Prevention
Site Search
 

HuGENet Reviews

δ-Aminolevulinic Acid Dehydratase (ALAD) Genotype and Lead Toxicity
Samir N. Kelada1,4, Erin Shelton2, Rachel B. Kaufmann3, and Muin J. Khoury1
back to review

 REFERENCES
  1. Wetmur JG, Bishop DF, Cantelmo C, et al. Human delta-aminolevulinate dehydratase: nucleotide sequence of a full-length cDNA clone. Proc Natl Acad Sci USA 1986;83:7703-7.
  2. Jaffe EK. The porphobilinogen synthase family of metalloenzymes. Acta Crystallogr D Biol Crystallogr 2000;56(Pt 2):115-28.
  3. Wetmur JG. Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden. Environ Health Perspect 1994;102 Suppl 3:215-9. 
  4. Battistuzzi G, Petrucci R, Silvagni L, et al. delta-Aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 1981; 45:223-9. 
  5. Wetmur JG, Kaya AH, Plewinska M, et al. Molecular characterization of the human delta-aminolevulinate dehydratase2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 1991;49:167-74. 
  6. Fleming DE, Chettle DR, Wetmur JG, et al. Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res 1998;77(1):49-61. 
  7. Alexander BH, Checkoway H, Costa-Mallen P, et al. Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect 1998;106(4):213-6. 
  8. Goedde HW, Rothhammer F, Benkmann HG, et al. Ecogenetic studies in Atacameno Indians. Hum Genet 1984;67(3):343-6. 
  9. Eiberg H, Mohr J, Nielsen LS. delta-Aminolevulinate dehydrase: synteny with ABO-AK1-ORM (and assignment to chromosome 9). Clin Genet 1983;23(2):150-4. 
  10. Juli E, Scheil HG, Gunther A. [Gene frequency of delta-aminolevulinate dehydratase (E.C. 4.2.1.24) in a West German population]. Anthropol Anz 1983;41(4):309-11. 
  11. Benkmann H-G, Bogdanski P, Goedde HW. Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum Hered 1983;33:62-4. 
  12. Scheil HG, Scheffrahn W. [Gene frequencies of the enzymes ALADH, GOT2, GPT, PGM3, SAHH and UMPK in a Swiss population]. Anthropol Anz 1987;45(3):255-60. 
  13. Kapotis C, Tsomi A, Babionitakis A, et al. The genetic polymorphism of aminolevulinate dehydratase (ALADH) in Greece. Hum Hered 1998;48(3):155-7. 
  14. Ben-Ezzer J, Oelsner H, Szeinberg A. Genetic polymorphism of delta-aminolevulinate dehydrase in several population groups in Israel. Hum Hered 1987;37(4):229-32. 
  15. Petrucci R, Leonardi A, Battistuzzi G. The genetic polymorphism of human delta-Aminolevulinate dehydratase in Italy. Hum Genet 1982;60:289-90.
  16. Komatsu N, Ose Y, Kido A, et al. Distribution of ALADH Types in Yamanashi Prefecture. Jpn J Legal Med 1987;41(1):1-3. 
  17. Sakai T, Morita Y, Araki T, et al. Relationship Between Delta-Aminolevulinic Acid Dehydratase Genotypes and Heme Precursors in Lead Workers. Am J Ind Med 2000;38:355-60. 
  18. Raczek E. Polymorphism of delta-aminolevulinate dehydratase in the upper Silesian population, Poland. Hum Hered 1994;44(3):172-4. 
  19. Amorim A, Rocha J, Santos MT. Distribution of ACP1, AK1 and ALAD polymorphisms in northern Portugal. Gene Geogr 1994;8(2):147-50. 
  20. Roychoudhury AK, Nei M. Human polymorphic genes: world distribution. New York, NY: Oxford University Press, 1988:54. 
  21. Garcia-Orad A, Aguirre AI, Mazon LI, et al. Polymorphism of delta-aminolevulinic acid dehydratase in Basque populations. Hum Hered 1987;37(5):321-2. 
  22. Caeiro B, Rey D. Genetic heterogeneity of delta-aminolevulinate dehydrase and phosphoglycolate phosphatase in north-west Spain. Hum Hered 1985;35(1):21-4. 
  23. Hsieh LL, Liou SH, Chen YH, et al. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J Occup Environ Med 2000;42(2):151-5. 
  24. Smith CM, Wang X, Hu H, et al. A polymorphism in the d-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 1995;103:248-253. 
  25. Astrin KH, Bishop DF, Wetmur JG, et al. delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann NY Acad Sci 1987;514:23-9. 
  26. Wetmur JG, Lehnert G, Desnick RJ. The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 1991;56(2):109-19. 
  27. Mahaffey K, McKinney J, Reigart JR. Lead and compounds. In: Lippmann M, ed. Environmental toxicants, human exposures and their health effects, 2nd ed. New York, NY: John Wiley and Sons, 2000: 481-521. 
  28. Goyer RA. Toxic Effects of Metals. In: Klaassen CD, ed. Casarett & Doull’s Toxicology, the basic science of poisons, 5th ed. New York, NY: McGraw-Hill, 1996: 691-736. 
  29. National Research Council (NRC). Measuring lead exposure in infants, children, and other sensitive populations. Washington, DC: NRC, 1990. 
  30. Lin-Fu JS. Vulnerability of children to lead exposure and toxicity: Part one. N Eng J Med 1973;289:1229-33. 
  31.  Ziegler EE, Edwards BB, Jensen RL, et al. Absorption and retention of lead by infants. Ped Res 1978; 12:29-34. 
  32. Mahaffey KR. Nutrition and lead: Strategies for public health. Environ Health Perspect 1995; 103 (Suppl 6):191-6. 
  33. National Institute of Occupational Health and Safety (NIOSH). Protecting workers exposed to lead-based paint hazards, a report to Congress. Cincinnati, OH: NIOSH, 1997. 
  34. Osterlow JF, Sharp DS, Hata B. Quality Control Data for Low Blood Lead Concentrations by Three Methods Used in Clinical Studies. J Analyt Toxicol 1990;14:8-11. 
  35. McElvaine MD, Orbach HG, Binder S, et al. Evaluation of erythrocyte protoporphyrin test as a screen for elevated blood lead levels, Chicago, Illinois, 1988-1989. J Pediatr 1991;119(4):548-550. 
  36. Schutz, AS, Skervfing J, Christoffersson JO. Chelatable level versus lead in human trabecular and compact bone. Sci Total Environ 1987;68:45-59.
  37. Pirkle JL, Kaufmann RB, Brody DJ, et al. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect 1998;11:745-50. 
  38. Lanphear BP, Byrd RS, Auinger P, et al. Community characteristics associated with children’s blood lead levels. Pediatrics 1998;101:264-71. 
  39. Sargent JD, Brown MJ, Freeman JL, et al. Childhood lead poisoning in Massachusetts communities: Its association with sociodemographic and housing characteristics. Am J Pub Health 1995; 85:528-34. 
  40. Baghurst, PA, McMichael AJ, Wigg NR. Environmental exposure to lead and children’s intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med 1992; 327:1279-84. 
  41. Friscancho AR, Ryan AS. Decreased stature associated with moderate blood lead concentrations in Mexican-American children. Am J Clin Nutr 1991;54:516-19. 
  42. Otto DA and Fox DA. Auditory and visual dysfunction following lead exposure. Neurotox 1993;14(2-3):191-207. 
  43. Banks EC, Ferretti LE, Shucard DW. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and behavioral evidence. Neurotox 1997;18(1):237-81. 
  44. Bellinger D, Dietrich KN. Low-level lead exposure and cognitive function in children. Pediatr Ann 1994;23(11):600-5. 
  45. Lanphear BP, Dietrich KN, Auinger P, et al. Subclinical lead toxicity in U.S. children and adolescents. Ped Res 2000;152A. 
  46. Schwartz J. Low-level lead exposure and children’s IQ: a meta-analysis and search for a threshold. Environ Res 1994;65:42-55. 
  47. Centers for Disease Control (CDC). Screening young children for lead poisoning: guidance for state and local public health officials.  Atlanta: CDC, 1997. 
  48. Lanphear BP. The paradox of lead poisoning prevention. Science 1998;1617-18. 
  49. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys. J Amer Med Assoc 1994;272(4):284-91. 
  50. CDC. Adult blood lead epidemiology and surveillance – United States, second and third quarters, 1998, and annual 1994-1997. Morbidity and Mortality Weekly Report 1999; 48(10):213-6. 
  51. Kappas A, Sassa S, Galbraith RA, et al. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease, 7th ed. New York:McGraw-Hill, 1995;2103-59. 
  52. Chisolm JJ Jr, Thomas DJ, Hamill TG. Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure in children. Clin Chem 1985;31:601-605. 
  53. Rogan WJ, Reigart JR, Gladen BC. Association of aminolevulinate dehydratase levels and ferrochelatase inhibition in childhood lead exposure. J Pediatr 1986;109:60-64. 
  54. Jaffe EK, Bagla S, Michini PA. Reevaluation of a sensitive indicator of early lead exposure. Measurement of porphobilinogen synthase in blood. Biol Trace Element Res 1991;28:223-31. 
  55. Warren MJ, Cooper JB, Wood SP, et al. Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem Sci 1998;23(6):217-21. 
  56. Muller WE, Snyder SH. delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann Neurol 1977;2:340-42. 
  57. Brennan MJ, Cantrill RC. delta-Aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature 1979;280:514-15. 
  58. Ziemsen B, Angerer J, Lehnert G, et al. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 1986;58:245-47. 
  59. Schwartz BS, Lee BK, Stewart W, et al. Associations of d-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 1995;142:738-45. 
  60. Bergdahl IA, Gerhardsson L, Schutz A, et al. Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health 1997;52(2):91-6. 
  61. Schwartz BS, Lee BK, Stewart W, et al. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med 1997;54(4):241-6. 
  62. Schwartz BS, Lee BK, Stewart W, et al. Associations of subtypes of hemoglobin with delta-aminolevulinic acid dehydratase genotype and dimercaptosuccinic acid-chelatable lead levels. Arch Environ Health 1997;52:97-103. 
  63. Sithisarankul P, Schwartz BS, Lee BK, et al. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med 1997;32:15-20. 
  64. Schwartz BS, Lee B-L, Lee G-S, et al. Associations of Blood Lead, Dimercaptosuccinic Acid-Chelatable Lead, and Tibia Lead with Polymorphisms in the Vitamin D Receptor and d-Aminolevulinic Acid Dehydratase Genes. Environ Health Perspect 2000;108(10):949-54. 
  65. Bergdahl IA, Grubb A, Schutz A, et al. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 1997;81(4):153-8. 
  66. Bellinger D, Hu H, Titlebaum L, et al. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 1994;49:98-105. 
  67. Doss M, Laubenthal F, Stoeppler M. Lead poisoning in inherited d-aminolevulinic acid dehydratase deficiency. Int Arch Occup Environ Health 1984;54:55-63. 
  68. Mahaffey KR, Gartside PS, Glueck CJ. Blood lead levels and dietary calcium intake in 1-11-year-old children: the Second National Health and Nutrition Examination Survey, 1976-1980. Pediatrics 1986;78:257-62. 
  69. Blake KCH, Mann M. Effect of calcium and phosphorus on the gastrointestinal absorption of 203 Pb in man. Environ Res 1983;30:188-94. 
  70. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11:1841-49. 
  71. Schwartz BS, Stewart WF, Kelsey K, et al. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect 2000;108(3):199-203. 
  72. Mahaffey-Six K, Goyer RA. Experimental enhancement of lead toxicity by low dietary calcium. J Lab Clin Med 1972;76:933-42. 
  73. Barton JC, Patton MA, Edwards CQ, et al. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med 1994; 124(2):193-8. 
  74. Åkesson A, Stål P, Vahter M. Phlebotomy increases cadmium uptake in hemochromatosis. Environ Health Perspect 2000 Apr;108(4):289-91. 
  75. Fujita, H, Sato K, Sano S. Increase in the amount of erythrocyte d-aminolevulinate dehydratase in workers with moderate lead exposure. Int Arch Occup Environ Health 1982; 50:287-97. 
  76. Boudene C, Despaux-Pages N, Comoy E, et al. Immunological and enzymatic studies of erythrocytic d-aminolevulinate dehydratase. Comparison of results obtained in normal and lead-exposed subjects. Int Arch Occup Environ Health 1984;55: 57-96.
Page last reviewed: July 1, 2001 (archived document)
Page last updated: November 2, 2007
Content Source: CDC's Office of Public Health Genomics